Singapore markets closed
Straits Times Index
3,264.53 -35.51 (-1.08%) S&P 500
5,186.97 -0.73 (-0.01%) Dow
38,946.65 +62.39 (+0.16%) Nasdaq
16,316.07 -16.49 (-0.10%) Bitcoin USD
62,584.28 -1,622.36 (-2.53%) CMC Crypto 200
1,332.40 +37.73 (+2.92%)
BPMC May 2024 95.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:08AM EDT. Market open.
| Previous close | 12.00 |
| Open | 12.00 |
| Bid | 12.20 |
| Ask | 16.50 |
| Strike | 95.00 |
| Expiry date | 2024-05-17 |
| Day's range | 12.00 - 12.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 22 |
ZacksZacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand have been highlighted in this Industry Outlook article.
PR NewswireBlueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective May 1, 2024, the Compensation Committee of Blueprint Medicines' Board of Directors granted non-qualified stock options to purchase an aggregate of 6,400 shares of its common stock and an aggregate of 3,200 restricted stock units (RSUs) to two new employees under Blueprint Medicines' 2020 Inducement Plan.
Zacks5 Biotech Stocks Worth Adding to Your Portfolio in 2024
New drug approvals and pipeline progress are likely to help maintain the momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position BMRN, BPMC, IMVT, KYMR and LGND well amid volatility.
© 2024 Yahoo. All rights reserved.